EUVIMED · CrossrefZeitschrift
Oncolytic Virotherapy
ISSN 2253-1572 · Informa UK Limited
Neueste Artikel
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
Oncolytic virus and PD-1/PD-L1 blockade combination therapy
Current understanding of reovirus oncolysis mechanisms
Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
Applications of coxsackievirus A21 in oncology
Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma
Myxoma virus therapy of human embryonal rhabdomyosarcoma in a nude mouse model
CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter
Novel oncolytic viral therapies in patients with thoracic malignancies
Proinflammatory response induced by Newcastle disease virus in tumor and normal cells
Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunity
Editorial announcing PubMed indexing of Oncolytic Virotherapy
Potential of oncolytic viruses in the treatment of multiple myeloma
The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses
Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies
Development and applications of oncolytic Maraba virus vaccines
Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
Oncolytic virotherapy in upper gastrointestinal tract cancers
Three-dimensional tumor cell cultures employed in virotherapy research
Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes
Oral poliovirus vaccine-induced programmed cell death involves both intrinsic and extrinsic pathways in human colorectal cancer cells
Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme
Virus–Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development
A cautionary note on the selectivity of oncolytic poxviruses
Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]
Virus–Receptor Interactions: Structural Insights For Oncolytic Virus Development
Impact of Induced Syncytia Formation on the Oncolytic Potential of Myxoma Virus
Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib
The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
EUVIMED